2007
DOI: 10.1016/j.ccr.2007.02.006 View full text |Buy / Rent full text
|
|

Abstract: HIF-2alpha promotes von Hippel-Lindau (VHL)-deficient renal clear cell carcinoma (RCC) tumorigenesis, while HIF-1alpha inhibits RCC growth. As HIF-1alpha antagonizes c-Myc function, we hypothesized that HIF-2alpha might enhance c-Myc activity. We demonstrate here that HIF-2alpha promotes cell-cycle progression in hypoxic RCCs and multiple other cell lines. This correlates with enhanced c-Myc promoter binding, transcriptional effects on both activated and repressed target genes, and interactions with Sp1, Miz1,… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
34
581
3
2

Publication Types

Select...

Relationship

0
0

Authors

Journals